ANDREASI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 436
EU - Europa 414
AS - Asia 241
SA - Sud America 8
Totale 1.099
Nazione #
US - Stati Uniti d'America 430
CN - Cina 155
SE - Svezia 152
IT - Italia 121
SG - Singapore 72
RU - Federazione Russa 54
GB - Regno Unito 21
DE - Germania 16
FI - Finlandia 16
IE - Irlanda 10
FR - Francia 8
IN - India 7
BR - Brasile 6
CA - Canada 6
NL - Olanda 6
CH - Svizzera 3
CL - Cile 2
HK - Hong Kong 2
JP - Giappone 2
PL - Polonia 2
PT - Portogallo 2
TW - Taiwan 2
AT - Austria 1
BE - Belgio 1
CZ - Repubblica Ceca 1
IR - Iran 1
Totale 1.099
Città #
Ashburn 109
Shanghai 63
Singapore 55
Milan 44
Boardman 34
New York 33
Lawrence 25
Princeton 25
Washington 21
Moscow 19
London 16
Helsinki 14
Dallas 13
Beijing 12
Los Angeles 11
Dublin 10
Guangzhou 7
Rome 7
Pune 5
Seattle 5
Tabira 5
Bolzano 3
Borgosesia 3
Council Bluffs 3
Munich 3
Ottawa 3
Philadelphia 3
Portland 3
St Petersburg 3
Banqiao 2
Bern 2
Botricello 2
Cureggio 2
Delianuova 2
Jinan 2
Krakow 2
Lappeenranta 2
Madone 2
Malosco 2
Matera 2
New Orleans 2
Nocera Inferiore 2
Pisa 2
San Jose 2
Santa Clara 2
Shenzhen 2
Toronto 2
Trieste 2
Wuxi 2
Xi'an 2
Amsterdam 1
Bomporto 1
Brno 1
Brussels 1
Buffalo 1
Campodolcino 1
Capriolo 1
Cesano Maderno 1
Cesena 1
Cosenza 1
Essen 1
Forest City 1
Forio 1
Fort Worth 1
Foshan 1
Frankfurt am Main 1
Gatchina 1
Gunzenhausen 1
Haining 1
Hangzhou 1
Hanover 1
Hong Kong 1
Houston 1
Huzhou 1
Jiaxing 1
Jinhua 1
Kunming 1
Lagoa Santa 1
Mumbai 1
Nantong 1
Newark 1
Palermo 1
Pittsburgh 1
Pombal 1
Presezzo 1
Prineville 1
Quanzhou 1
San Francisco 1
Seregno 1
Sesto San Giovanni 1
Shantou 1
Suzhou 1
Taizhou 1
Vimercate 1
Woodbridge 1
Xiamen 1
Yekaterinburg 1
Zhengzhou 1
Totale 647
Nome #
ROLE OF CHROMOGRANIN A-DERIVED FRAGMENTS AND OTHER BIOMARKERS IN PANCREATIC NEOPLASMS: FOCUS ON NEUROENDOCRINE TUMORS 89
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 32
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 30
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 30
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 29
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 29
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 29
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 28
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 26
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 26
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life 24
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 23
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 22
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 22
Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors: How to Deal with them in Clinical Practice? 21
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms 21
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors 21
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 20
Update on gastroenteropancreatic neuroendocrine tumors 20
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 20
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 20
Prognostic role of examined and positive lymph nodes after distal pancreatectomy for non-functioning neuroendocrine neoplasms 20
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 19
Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis 19
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 19
Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) 19
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma 19
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 19
Implications of increased serum amylase after pancreaticoduodenectomy: toward a better definition of clinically relevant postoperative acute pancreatitis 19
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 18
Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis 18
A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy 18
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 18
Local treatment for focal progression in metastatic neuroendocrine tumors 18
Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms 17
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 17
New Surgical Strategies 15
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 15
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 15
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors 15
Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting 15
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 14
Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After Pancreatoduodenectomy 14
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 14
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 13
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 13
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral center 13
Prognostic significance of nodal micrometastases of non-functioning pancreatic neuroendocrine tumours 13
Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours 13
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs) 13
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 12
Could Glycated Hemoglobin be Leakage Predictor in Sleeve Gastrectomy? A Retrospective Observational Study on 4233 Patients 12
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 12
Non functional pancreatic neuroendocrine tumors 12
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 11
Reply to Letter to the Editor: Role of Preoperative High-Resolution Manometry in the Identification of Patients at High Risk of Postoperative GERD Symptoms 1 Year After Sleeve Gastrectomy 10
Evaluation of factors predicting loss of benefit provided by laparoscopic distal pancreatectomy compared to open approach 10
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 10
Role of Preoperative High-Resolution Manometry in the Identification of Patients at High Risk of Postoperative GERD Symptoms 1 Year After Sleeve Gastrectomy 8
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 7
Exploring definitions of graft pancreatitis following pancreas transplantation: A scoping review 7
Role of chromogranin A-derived fragments after resection of nonfunctioning pancreatic neuroendocrine tumors 7
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 7
Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis 6
Clinical and Financial Validation of the International Study Group for Pancreatic Surgery (ISGPS) Definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study 3
Totale 1.188
Categoria #
all - tutte 13.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 1 0 0
2020/202121 0 0 0 1 0 17 2 0 1 0 0 0
2021/202230 0 1 1 6 4 2 10 0 0 2 1 3
2022/2023290 57 48 22 19 9 43 25 28 17 6 8 8
2023/2024522 18 25 69 53 61 108 6 47 4 13 30 88
2024/2025324 118 44 47 51 64 0 0 0 0 0 0 0
Totale 1.188